Home
       
STOCK MARKETS


Back

10 Last viewed shares   
 
Strategy & Goals
  Strategy & Goals
  Mission, Vision, and Values Our Mission To contribute to the enrichment of quality of life around the world through the creation of innovative ...
  Read more... 
President’s Message
  President’s Message
  A Message from President and CEO Nobuo Hanai We will fully leverage our unique biotechnology strengths to become a global specialty pharmaceutical company. ...
  Read more... 
Year in Brief
  Year in Brief
  REVENUE The consolidated revenue of the Group for the year 2018 amounted to approximately RMB 740,422,000, comparing to approximately RMB 497,694,000 for the ...
  Read more... 
   

H. Lundbeck A/S

    Print this page Print this page    Send to a Friend E-mail this page to your friend    Disclaimer

SHARE DATA GRAPH TECHNICAL ANALYSIS
Select class of Share
H. Lundbeck A (FRK)‎  
Last 4,59      Change % -0,22 
Add to Portfolio
Add to Watchlist
Add to Alerts

10 LAST TRADES EUR
Time Last Volume
Displayed time is based on the time zone of your choice on Euroland.com
Refresh
ChartImage
 
QUOTES EUR
Time 17:15:01
Last 4,59
Change % -0,22 
Change -0,01 
Bid/Ask 4,50 / 4,67
Open 4,56
High/Low 4,59 / 4,53
Volume 0
Previous Close 4,60
52 Weeks High 4,77
52 Weeks Low 3,67
52 Weeks %   14,76 
YTD %   19,78 
Volatility 23,70
Beta 0,33
Correlation 0,17
MARKET DATA
Symbol LDBB
Market  Frankfurt
List  Open Market
Domestic Industry  Pharmaceutical & Healthcare
Euroland-Industry  Pharmaceuticals manufactures
Shares (mil)1 199,15
Market Cap (mil) 915,09
1 - Number of shares in specific class of share. Otherwise it is total number of shares issued.

INDICES
 -

Data delayed at least 15 minutes. From Hanoi & HoChiMinh data is real time. From Milan, Dublin & Tokyo data is as end of day.
Data provided by vwd group Switzerland AG & MOEX.

 
 
   Privacy Policy | Disclaimer | Set this page as your homepage| © Euroland.com 2000-2024